Huafeng Xie

5.0k total citations · 1 hit paper
36 papers, 3.7k citations indexed

About

Huafeng Xie is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Huafeng Xie has authored 36 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Immunology and 10 papers in Hematology. Recurrent topics in Huafeng Xie's work include Epigenetics and DNA Methylation (17 papers), Genomics and Chromatin Dynamics (7 papers) and Acute Myeloid Leukemia Research (6 papers). Huafeng Xie is often cited by papers focused on Epigenetics and DNA Methylation (17 papers), Genomics and Chromatin Dynamics (7 papers) and Acute Myeloid Leukemia Research (6 papers). Huafeng Xie collaborates with scholars based in United States, China and Spain. Huafeng Xie's co-authors include Thomas Graf, Ru Feng, Min Ye, Stuart H. Orkin, Matthias Stadtfeld, Luísa de Andrés-Aguayo, Fiona J. Pixley, Jian Xu, Yuko Fujiwara and Minh Nguyen and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Huafeng Xie

36 papers receiving 3.6k citations

Hit Papers

Stepwise Reprogramming of... 2004 2026 2011 2018 2004 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Huafeng Xie 2.8k 717 645 514 323 36 3.7k
Neil P. Rodrigues 1.8k 0.6× 637 0.9× 1.1k 1.7× 598 1.2× 280 0.9× 34 3.0k
Barry Grimes 1.5k 0.5× 537 0.7× 1.1k 1.7× 754 1.5× 309 1.0× 17 2.5k
Petter Woll 1.3k 0.4× 755 1.1× 777 1.2× 539 1.0× 235 0.7× 48 2.2k
Hideyuki Oguro 1.4k 0.5× 785 1.1× 1.2k 1.9× 359 0.7× 247 0.8× 30 2.7k
Christine B.F. Thien 1.8k 0.6× 809 1.1× 417 0.6× 712 1.4× 233 0.7× 38 2.8k
Marcus B. Valentine 1.7k 0.6× 666 0.9× 395 0.6× 1.3k 2.5× 415 1.3× 39 3.6k
Sharon Boast 1.2k 0.4× 705 1.0× 691 1.1× 309 0.6× 254 0.8× 25 2.4k
Doris Steinemann 1.6k 0.6× 298 0.4× 445 0.7× 551 1.1× 505 1.6× 127 2.8k
Fong‐Ying Tsai 2.3k 0.8× 762 1.1× 804 1.2× 588 1.1× 264 0.8× 9 3.3k
Varda Negreanu 1.4k 0.5× 1.2k 1.6× 493 0.8× 532 1.0× 400 1.2× 25 2.7k

Countries citing papers authored by Huafeng Xie

Since Specialization
Citations

This map shows the geographic impact of Huafeng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huafeng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huafeng Xie more than expected).

Fields of papers citing papers by Huafeng Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huafeng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huafeng Xie. The network helps show where Huafeng Xie may publish in the future.

Co-authorship network of co-authors of Huafeng Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Huafeng Xie. A scholar is included among the top collaborators of Huafeng Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huafeng Xie. Huafeng Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Long, Jie, Qiong Yang, Ming Zhou, et al.. (2024). Bone marrow CD8+ Trm cells induced by IL-15 and CD16+ monocytes contribute to HSPC destruction in human severe aplastic anemia. Clinical Immunology. 263. 110223–110223. 1 indexed citations
2.
Cai, Wenqing, Jialiang Huang, Qian Zhu, et al.. (2020). Enhancer dependence of cell-type–specific gene expression increases with developmental age. Proceedings of the National Academy of Sciences. 117(35). 21450–21458. 31 indexed citations
3.
Jadhav, Unmesh, Alessia Cavazza, Kushal K. Banerjee, et al.. (2019). Extensive Recovery of Embryonic Enhancer and Gene Memory Stored in Hypomethylated Enhancer DNA. Molecular Cell. 74(3). 542–554.e5. 55 indexed citations
4.
Ma, Ke-Yue, Jianjun Shen, Jessica N. Lancaster, et al.. (2018). Polycomb Repressive Complex 2 is essential for development and maintenance of a functional TEC compartment. Scientific Reports. 8(1). 14335–14335. 5 indexed citations
5.
Hsu, Jessie Hao-Ru, Guillaume Adelmant, Jialiang Huang, et al.. (2017). PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. Cancer Research. 77(17). 4613–4625. 26 indexed citations
6.
Erb, Michael A., Thomas G. Scott, Bin E. Li, et al.. (2017). Transcription control by the ENL YEATS domain in acute leukaemia. RePEc: Research Papers in Economics. 1 indexed citations
7.
Xie, Huafeng, Cong Peng, Jialiang Huang, et al.. (2016). Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2. Cancer Discovery. 6(11). 1237–1247. 73 indexed citations
8.
Serresi, Michela, Gaetano Gargiulo, Natalie Proost, et al.. (2016). Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer. Cancer Cell. 29(2). 241–241. 5 indexed citations
9.
Serresi, Michela, Gaetano Gargiulo, Natalie Proost, et al.. (2016). Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer. Cancer Cell. 29(1). 17–31. 91 indexed citations
10.
Danis, Etienne, Simone S. Riedel, Nan Zhu, et al.. (2015). Inactivation of Eed impedes MLL-AF9–mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model. Experimental Hematology. 43(11). 930–935.e6. 19 indexed citations
11.
H., Ki, Holly A. Hung, Rajini Srinivasan, et al.. (2015). Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2. Journal of Neuroscience. 35(22). 8640–8652. 46 indexed citations
12.
Xu, Jian, Zhen Shao, Dan Li, et al.. (2015). Developmental Control of Polycomb Subunit Composition by GATA Factors Mediates a Switch to Non-Canonical Functions. Molecular Cell. 57(2). 304–316. 102 indexed citations
13.
Xie, Huafeng, Jian Xu, Jessie Hao-Ru Hsu, et al.. (2013). Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner. Cell stem cell. 14(1). 68–80. 241 indexed citations
14.
Yu, Ming, Tali Mazor, Hui Huang, et al.. (2012). Direct Recruitment of Polycomb Repressive Complex 1 (PRC1) to Chromatin by Core Binding Transcription Factors. Europe PMC (PubMed Central). 160 indexed citations
15.
Xie, Huafeng, et al.. (2010). Reprogramming of Committed Lymphoid Cells by Enforced Transcription Factor Expression. Methods in molecular biology. 636. 219–232. 2 indexed citations
16.
Yu, Ming, Laura Riva, Huafeng Xie, et al.. (2009). Insights into GATA-1-Mediated Gene Activation versus Repression via Genome-wide Chromatin Occupancy Analysis. Molecular Cell. 36(4). 682–695. 250 indexed citations
17.
Crump, Michael, Bertrand Coiffier, Eric D. Jacobsen, et al.. (2008). Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Annals of Oncology. 19(5). 964–969. 139 indexed citations
18.
Xie, Huafeng, Min Ye, Ru Feng, & Thomas Graf. (2004). Stepwise Reprogramming of B Cells into Macrophages. Cell. 117(5). 663–676. 720 indexed citations breakdown →
19.
Neumeister, Peter, Fiona J. Pixley, Ying Xiong, et al.. (2003). Cyclin D1Governs Adhesion and Motility of Macrophages. Molecular Biology of the Cell. 14(5). 2005–2015. 131 indexed citations
20.
Ye, Min, Hiromi Iwasaki, Matthias Stadtfeld, et al.. (2003). Hematopoietic Stem Cells Expressing the Myeloid Lysozyme Gene Retain Long-Term, Multilineage Repopulation Potential. Immunity. 19(5). 689–699. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026